Up to $2000 USD to be applied towards scientific conferences, workshops or courses that will build core competencies and transferrable skills and/or share your research.
Intended Audience: Graduate students and postdocs
Award Cycle: 1 April – 31 May 2024
GTTC is pleased to announce TWO awards for 2024:
Intended Audience: Graduate students and postdocs
Award Cycle: 11 April – 31 May, 2024
More Information about the Genetic Toxicology Technical Committee
1,500-2000K travel award to attend scientific conferences, workshops and professional meetings to help trainee build their professional network and to increase their knowledge in topics related to immuno-safety
Intended Audience: Graduate students and postdocs
Award Cycle: Closed
Recipients:
Ishita Choudhary (Louisiana State University)
Jaclynn Meshanni (Rutgers University)
More Information about the Immuno-Safety Technical Committee
Up to $500 Award to
Intended Audience: Early career (1-5 yrs post degree)
Award Cycle: Launched in 2022 1x/yr
More Information about the Genetic Toxicology Technical Committee
Cardiac Safety Early Career Seminar Award Series- $500 award
Intended Audience: Post-doctoral or early career
Award Cycle: Launched in 2022
DART Emerging Science Award
Intended Audience: Graduate or Post-doctoral trainee
Award Cycle: Launching in 2023
More Information about the Developmental and Reproductive Toxicology Committee
Goal to s to increase awareness about careers in the immunosafety and immuno-pharmacology fields, with a target audience of graduate students, post-docs, and early career scientists. This webinar was structured to allow meaningful Q&A interactions between the audience and speakers to give insight on their respective career pathways.
Intended Audience: Graduate Students, Post docs, early career scientist
Event Dates: March 26, 2024
Award Cycle: Launched in 2021
More Information about the Immuno-Safety Technical Committee
DART Career Symposium was designed to increase awareness of DART career paths and training for the next generation of scientists. This event features a keynote address, career panel and speed networking session.
Intended Audience: All
Award Cycle: Launched in 2022. Spring Career Symposium is 12 April 2023.
More Information about the Developmental and Reproductive Toxicology Committee
Launching in 2023
Co-Sponsoring Institution: Newcastle University
Status: Initiated Fall 2022
More Information about Cell Therapy – TRAcking, Circulation, & Safety Committee
To support the NHP, Second species, AOP
Co-Sponsoring Institution: CBG-MEB/RIVM, RIVM
Status: In development, Peter Theunissen (now at CBG- MEG), Gina Mennen
More Information about the Developmental and Reproductive Toxicology Committee
Pilot matching program in Immuno-safety
Co-Sponsoring Institution:SOT ITSS and standalone program with interested trainee
Status: Standalone: Initiated Spring 2022, ITSS: Fall 2022
More Information about the Immuno-Safety Technical Committee
Mentor- mentee matching program in DART
Co-Sponsoring Institution:All with interested trainees from various universities
Status: To launch in 2023
More Information about the Developmental and Reproductive Toxicology Committee
Hired students (MS and PhD level) to support literature reviews of botanicals with respect to safety.
Co-mentored PharmD students with P&G to collect literature related to botanical safety
(Summer) intern worked on collecting information on herbal drug interactions
Status: Work took place in 2021 and 2022.
(Summer) intern worked to summarize commonly used EDC assays
Status: Work took place in 2022 and will continue into 2023
More informaiton about Next Generation Ecological Risk Assessment
(Summer) intern work to collect rat liver carcinogenicity data
Status: Work took place in 2022 and will continue into 2023
More Infomation about the Emerging Systems Toxicology for the Assessment of Risk Committee
var _ctct_m = “f5604902b70937f5acaf35faa2fe750d”;
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.